comparative study of therapeutic efficacy of cryotherapy with and without intralesional vitamine D3 in the treatment of recalcitrant warts

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200513047434N1

Enrollment

Registered

2020-05-28

Start date

2020-05-18

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recalcitrant warts. Viral warts

Interventions

Intervention 1: Intervention group: Group A:every 20 patients are initially treated with cryotherap (cryotherapy spray contains liquid nitrogen, that is sprayed on the lesion from a distance of 1-2cm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: having at least one recalcitrant wart

Exclusion criteria

Exclusion criteria: facial, oral and genital warts pregnancy and lactation immune deficiency local infection and inflamation over injection sites epilepsy history of colloid formation over injection sites chronic kidney disease cold urticaria hypercalcemia or hypervitaminosis d injection phobia

Design outcomes

Primary

Measure	Time frame
Healing of warts. Timepoint: every 2 weeks after first session of therapy. Method of measurement: physical examination.	—

Secondary

Measure	Time frame
Treatment side effects. Timepoint: every 2 weeks after first session of therapy. Method of measurement: physical examination and history taking from the patient.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfsaneh Radmehr

Tabriz University of Medical Sciences

radmehra@tbzmed.ac.ir+98 41 3332 2191

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026